Sign in

CIK 0001731348

  • Large accelerated filer

Tilray Brands, Inc.

Sign in to watch
Ticker
TLRY
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
May 31
Entity type
Operating
EIN
824310622
Phone
+1 519-322-8800
Business address
445 PARK AVENUE, NEW YORK, NY, 10022
Former names
Tilray, Inc.
  1. 4 Other disposition Director disposed of 953,519 shares (other)
  2. 4 Grant or award Chief Financial Officer acquired 33,360 shares (grant or award)
  3. 4 Grant or award Chief Operating Officer acquired 33,360 shares (grant or award)
  4. 4 Option exercise Director acquired 2,187 shares (option exercise)
  5. 4 Option exercise Director acquired 2,187 shares (option exercise)
  6. 4 Other disposition Director disposed of 317,782 shares (other)
  7. 4 Grant or award Chief Operating Officer acquired 56,738 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 53,191 shares (grant or award)
  9. 4 Other disposition Director disposed of 3,220 shares (other)
  10. 4 Other disposition President and CEO disposed of 13,211 shares (other)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Option exercise Director acquired 2,187 shares (option exercise)
  14. 4 Shares withheld for taxes President and CEO gave up 12,777 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Corporate Dev Officer gave up 3,303 shares (to pay taxes)
  16. 4 Other disposition Director disposed of 217,982 shares (other)
  17. 4 Open-market sale Director sold 2,200 shares at $10.00 ($22,000)
  18. 4 Option exercise Director acquired 2,188 shares (option exercise)
  19. 4 Option exercise Director acquired 2,188 shares (option exercise)
  20. 4 Open-market sale President and CEO sold 400,000 shares at an average $9.88 ($3,953,291)

Page 11 of 17 · 334 filings